A groundbreaking invention combines 3D printing and AI to revolutionize cancer diagnosis in Kenya. Led by Dr. Daniel Maitethia, a physics lecturer and researcher, this innovation has gained national recognition for its potential to transform cancer care. The 3D-printed telepathology microscope, integrated with AI, can identify cancer cells with remarkable speed and accuracy, offering a cheaper and faster alternative to traditional methods. The idea originated from a masters thesis focused on malaria diagnosis, but the team realized its potential for cancer detection. The microscope's design includes 3D-printed plastic parts, optics, electronics, and a compact computer, enabling whole-slide imaging and remote diagnosis. This innovation addresses the scarcity of pathologists in Africa, allowing medical lab technicians to process tissue samples and capture high-resolution images. Multiple pathologists worldwide can then review these images and share diagnostic reports, ensuring timely and affordable cancer care. With a local manufacturing cost of around $232, this invention has the potential to significantly impact cancer diagnosis across Kenya and beyond, making healthcare more accessible and efficient.
